suspensionsformulierungen with an active ingredient, a poloxamer or meroxapol - surfactant and a glycol and their use for the production of a drug for the treatment of eye diseases

摘要

Topical aqueous suspension compositions of sparingly soluble ophthalmic drugs are disclosed. The compositions comprise a combination of a poloxamer or meroxapol surfactant and a glycol tonicity-adjusting agent such as propylene glycol.